Finding the Right Tenofovir/Emtricitabine Regimen for Pre-Exposure Prophylaxis (PrEP) in Transgender Women

NCT03060785 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

HIV Prevention

Interventions

DRUG: Tenofovir Disoproxil Fumarate/Emtricitabine

Sponsor

Johns Hopkins University